相似文献
1
Diet, β-glucocerebrosidase deficiency, and Parkinson's disease.
J Lipid Res. 2024 Dec;65(12):100689. doi: 10.1016/j.jlr.2024.100689. Epub 2024 Oct 28.
2
Lysosomal trafficking defects link Parkinson's disease with Gaucher's disease.
Mov Disord. 2016 Nov;31(11):1610-1618. doi: 10.1002/mds.26802. Epub 2016 Sep 13.
3
Advances in GBA-associated Parkinson's disease--Pathology, presentation and therapies.
Neurochem Int. 2016 Feb;93:6-25. doi: 10.1016/j.neuint.2015.12.004. Epub 2015 Dec 30.
4
Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance.
J Neurochem. 2016 Oct;139 Suppl 1:198-215. doi: 10.1111/jnc.13517. Epub 2016 Feb 10.
5
Glucocerebrosidase Activity is Reduced in Cryopreserved Parkinson's Disease Patient Monocytes and Inversely Correlates with Motor Severity.
J Parkinsons Dis. 2021;11(3):1157-1165. doi: 10.3233/JPD-202508.
6
Glucocerebrosidase as a therapeutic target for Parkinson's disease.
Expert Opin Ther Targets. 2020 Apr;24(4):287-294. doi: 10.1080/14728222.2020.1733970. Epub 2020 Feb 27.
7
Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells.
Brain. 2014 May;137(Pt 5):1481-95. doi: 10.1093/brain/awu020. Epub 2014 Feb 25.
8
Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease.
Brain. 2014 Mar;137(Pt 3):834-48. doi: 10.1093/brain/awt367. Epub 2014 Jan 28.
9
Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.
Brain. 2015 Sep;138(Pt 9):2648-58. doi: 10.1093/brain/awv179. Epub 2015 Jun 27.
10
White matter abnormalities in Parkinson's disease patients with glucocerebrosidase gene mutations.
Mov Disord. 2013 Jun;28(6):772-8. doi: 10.1002/mds.25397. Epub 2013 Feb 15.
本文引用的文献
1
6-O-alkyl 4-methylumbelliferyl-β-D-glucosides as selective substrates for GBA1 in the discovery of glycosylated sterols.
J Lipid Res. 2024 Nov;65(11):100670. doi: 10.1016/j.jlr.2024.100670. Epub 2024 Oct 10.
2
Gaucher disease provides a unique window into Parkinson disease pathogenesis.
Nat Rev Neurol. 2024 Sep;20(9):526-540. doi: 10.1038/s41582-024-00999-z. Epub 2024 Aug 6.
3
Lipid Composition Analysis and Characterization of Acyl Sterol Glycosides in Adzuki and Soybean Cultivars by Non-Targeted LC-MS.
Foods. 2023 Jul 21;12(14):2784. doi: 10.3390/foods12142784.
4
Mutant glucocerebrosidase impairs α-synuclein degradation by blockade of chaperone-mediated autophagy.
Sci Adv. 2022 Feb 11;8(6):eabm6393. doi: 10.1126/sciadv.abm6393. Epub 2022 Feb 9.
5
CRISPR Interference-Based Platform for Multimodal Genetic Screens in Human iPSC-Derived Neurons.
Neuron. 2019 Oct 23;104(2):239-255.e12. doi: 10.1016/j.neuron.2019.07.014. Epub 2019 Aug 15.
6
Lysosomal phospholipase A2.
Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Jun;1864(6):932-940. doi: 10.1016/j.bbalip.2018.07.012. Epub 2018 Aug 2.
7
The BSSG rat model of Parkinson's disease: progressing towards a valid, predictive model of disease.
EPMA J. 2017 Sep 4;8(3):261-271. doi: 10.1007/s13167-017-0114-6. eCollection 2017 Sep.
8
CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy.
Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):12101-6. doi: 10.1073/pnas.1108197108. Epub 2011 Jul 5.
9
Acid β-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter α-synuclein processing.
Ann Neurol. 2011 Jun;69(6):940-53. doi: 10.1002/ana.22400. Epub 2011 Apr 6.
10
Environmental neurotoxin-induced progressive model of parkinsonism in rats.
Ann Neurol. 2010 Jul;68(1):70-80. doi: 10.1002/ana.22018.
Zotero 插件